Geode Capital Management, LLC Corcept Therapeutics Inc Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,157,785 shares of CORT stock, worth $65.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,157,785

Previous 2,045,646 5.48%

Holding current value

$65.1 Million

Previous $66.4 Million 18.19%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $2.37 Million - $3.08 Million	112,139 Added 5.48%	2,157,785 $54.4 Million
Q4 2023 Feb 13, 2024	BUY	$24.82 - $32.88 $2.18 Million - $2.89 Million	87,959 Added 4.49%	2,045,646 $66.4 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $4.68 Million - $7.2 Million	212,897 Added 12.2%	1,957,687 $53.3 Million
Q2 2023 Aug 11, 2023	SELL	$21.44 - $25.15 $1.05 Million - $1.24 Million	-49,137 Reduced 2.74%	1,744,790 $38.8 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $1.39 Million - $1.77 Million	72,426 Added 4.21%	1,793,927 $38.9 Million

Q4 2022 Feb 13, 2023	BUY	$19.95 - $29.96 $1.49 Million - $2.24 Million	74,718 Added 4.54%	1,721,501 $35 Million
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $427,458 - $503,950	17,306 Added 1.06%	1,646,783 $42.2 Million
Q2 2022 Aug 12, 2022	SELL	$17.33 - $25.3 $648,193 - $946,295	-37,403 Reduced 2.24%	1,629,477 $38.7 Million
Q1 2022 May 13, 2022	SELL	$16.53 - $25.21 $1.06 Million - $1.61 Million	-63,992 Reduced 3.7%	1,666,880 $37.5 Million
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $1.27 Million - $1.74 Million	-74,533 Reduced 4.13%	1,730,872 $34.3 Million
Q3 2021 Nov 12, 2021	SELL	$19.68 - $22.53 $76,850 - $87,979	-3,905 Reduced 0.22%	1,805,405 $35.5 Million
Q2 2021 Aug 13, 2021	BUY	$19.97 - $24.43 $760,956 - $930,905	38,105 Added 2.15%	1,809,310 $39.8 Million
Q1 2021 May 12, 2021	BUY	$23.49 - $30.56 $2.91 Million - $3.79 Million	123,882 Added 7.52%	1,771,205 $42.1 Million
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $2.27 Million - $3.69 Million	135,198 Added 8.94%	1,647,323 $43.1 Million
Q3 2020 Nov 13, 2020	SELL	$12.46 - $19.98 $147,389 - $236,343	-11,829 Reduced 0.78%	1,512,125 $26.3 Million
Q2 2020 Aug 13, 2020	BUY	$11.0 - $18.26 $491,623 - $816,094	44,693 Added 3.02%	1,523,954 $25.6 Million
Q1 2020 May 14, 2020	BUY	$10.11 - $14.04 $471,682 - $655,036	46,655 Added 3.26%	1,479,261 $17.6 Million
Q4 2019 Feb 13, 2020	BUY	$12.06 - $16.96 $195,456 - $274,870	16,207 Added 1.14%	1,432,606 $17.3 Million
Q3 2019 Nov 12, 2019	BUY	$10.41 - $14.66 $332,360 - $468,049	31,927 Added 2.31%	1,416,399 $20 Million
Q2 2019 Aug 14, 2019	BUY	$9.78 - $12.76 $1.22 Million - $1.59 Million	124,903 Added 9.92%	1,384,472 $15.4 Million
Q1 2019 May 14, 2019	BUY	$10.03 - $15.71 $847,886 - $1.33 Million	84,535 Added 7.19%	1,259,569 $14.8 Million
Q4 2018 Feb 13, 2019	BUY	$11.29 - $17.19 $967,609 - $1.47 Million	85,705 Added 7.87%	1,175,034 $15.7 Million
Q3 2018 Nov 13, 2018	BUY	$12.27 - $15.65 $1.35 Million - $1.72 Million	110,170 Added 11.25%	1,089,329 $15.3 Million
Q2 2018 Aug 14, 2018	BUY	$15.3 - $19.69 $1.54 Million - $1.99 Million	100,904 Added 11.49%	979,159 $15.4 Million
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $978,916 - $1.71 Million	-67,095 Reduced 7.1%	878,255 $14.4 Million
Q4 2017 Feb 13, 2018	SELL	$15.77 - $20.72 $277,662 - $364,817	-17,607 Reduced 1.83%	945,350 $17.1 Million
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $1.21 Million - $1.9 Million	98,635 Added 11.41%	962,957 $18.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	864,322	864,322 $10.2 Million

Others Institutions Holding CORT

# of Institutions

314

Shares Held

93.8M

Call Options Held

2.02M

Put Options Held

3.24M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.23B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Corcept Therapeutics Inc Transaction History